Leos MX Eye Drop is a combination ophthalmic solution containing Loteprednol etabonate 0.5% w/v, a corticosteroid with potent anti-inflammatory properties, and Moxifloxacin 0.5% w/v, a broad-spectrum fluoroquinolone antibiotic. This formulation is indicated for the treatment of ocular inflammatory conditions accompanied by bacterial infections or at risk of secondary bacterial infections, such as conjunctivitis, keratitis, and postoperative inflammation following ocular surgery. Loteprednol etabonate acts by inhibiting the release of inflammatory mediators, thereby reducing redness, swelling, and discomfort, while Moxifloxacin effectively inhibits bacterial DNA gyrase and topoisomerase IV, preventing bacterial replication and eliminating susceptible pathogens. Leos MX Eye Drop is administered topically, ensuring localized therapeutic effect with minimal systemic absorption. It is essential to use this medication under ophthalmologic supervision to monitor for potential side effects, including increased intraocular pressure, delayed wound healing, or hypersensitivity reactions. Contraindications include viral, fungal, or mycobacterial ocular infections where corticosteroids may exacerbate the condition. Patients should adhere strictly to prescribed dosing regimens and avoid contact lens use during treatment unless otherwise advised. Leos MX Eye Drop offers an effective dual-action approach for managing inflammatory ocular conditions complicated by bacterial infections.